|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 31/4535 | (2006.01) |
| (11) | Patento numeris | 3072504 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16163199.9 |
| Europos patento paraiškos padavimo data | 2007-01-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 756937 P | 2006-01-06 | US | |
| 650174 | 2007-01-05 | US |
| (72) |
PALMER, Pamela, US
SCHRECK, Thomas, US
TZANNIS, Stelios, US
HAMEL, Larry, US
POUTIATINE, Andrew, US
|
| (73) |
AcelRx Pharmaceuticals, Inc.,
351 Galveston Dr, Redwood City, CA 94063,
US
|
| (54) | SMALL-VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS |
| SMALL-VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS |